3D-microenvironments initiate TCF4 expression rescuing nuclear β-catenin activity in MCF-7 breast cancer cells

Sara Sergio1, Addolorata Maria Luce Coluccia2, Enrico Domenico Lemma3

  • 1Istituto Italiano di Tecnologia, Center for Biomolecular Nanotechnologies, via Barsanti snc, 73010 Arnesano, Italy; Dipartimento di Scienze e Tecnologie Biologiche e Ambientali, Università del Salento, via per Monteroni, 73100 Lecce, Italy.

Acta Biomaterialia
|December 18, 2019
PubMed

Insights

Three-dimensional (3D) microenvironments can activate nuclear beta-catenin signaling in breast cancer cells, boosting proliferation and invasiveness. This finding offers new insights into mechanotransduction and potential personalized breast cancer treatments.

Area of Science:

  • Oncology
  • Biophysics
  • Cell Biology

Background:

  • Mechanical cues in the tumor microenvironment influence cancer cell behavior like invasion and proliferation.
  • Beta-catenin is a key protein in mechanotransduction and tumorigenesis, but its nuclear localization is heterogeneous in breast cancers.
  • MCF-7 breast cancer cells have impaired nuclear beta-catenin signaling due to low lymphoid enhancer factor/T cell factor (LEF/TCF) levels.

Purpose of the Study:

  • To investigate how mechanical cues affect MCF-7 breast cancer cells with defective beta-catenin nuclear uptake.
  • To explore the role of the 3D microenvironment in regulating beta-catenin activity and cancer cell behavior.

Main Methods:

  • Utilized three-dimensional (3D) microscaffolds fabricated via two-photon lithography.
  • Cultured MCF-7 human breast cancer cells on these 3D scaffolds.
  • Analyzed nuclear beta-catenin localization, TCF4 expression, and vimentin levels.

Main Results:

  • Engineered 3D microenvironments induced nuclear beta-catenin accumulation in MCF-7 cells.
  • Observed rescue of defective TCF4 expression and enhanced invasiveness.
  • Detected increased vimentin expression, indicating an epithelial-to-mesenchymal transition (EMT).
  • Demonstrated that blocking beta-catenin/TCF activity abrogated the increased cell proliferation.

Conclusions:

  • 3D microenvironments are sufficient to activate TCF4-dependent beta-catenin nuclear activity in MCF-7 cells, independent of initial nuclear accumulation defects.
  • This activation promotes cell proliferation and invasiveness, suggesting a role in breast cancer progression.
  • The study provides a platform to dissect mechanotransduction in breast cancer and may inform personalized treatment strategies considering pathway heterogeneity.

Related Concept Videos

Catenins01:23

Catenins

Catenins are characterized by multiple binding domains and dynamic structures that allow them to function as linker proteins in cell junction complexes. All catenins, except α-catenin, contain a characteristic protein sequence called the armadillo repeat and are therefore also called armadillo proteins.
Catenins in Cell Junctions
Catenins bind to cell adhesion molecules such as cadherins and link them to different cytoskeletal proteins depending on the type of cell junction. At the...
2.9K
The Tumor Microenvironment02:17

The Tumor Microenvironment

Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...
7.6K
TGF - β Signaling Pathway01:16

TGF - β Signaling Pathway

The TGF-β signaling pathway regulates cell growth, differentiation, adhesion, motility, and development. TGF-β ligands that induce TGF-β signaling are synthesized in their latent form. Several proteases or cell surface receptors such as integrins act upon the latent form, releasing the active ligand. There are three types of mammalian TGF-βs: (TGF-β1, TGF-β2, and TGF-β3) that bind as homodimers or heterodimers to TGF-β receptors. The TGF-β receptors...
10.3K